NCT01462084View on ClinicalTrials.gov

Effectiveness of Adaptive Servoventilation (ASV) in Patients With Central Sleep Apnea Due to Chronic Opioid Use

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

November 30, 2012

Study Completion Date

December 31, 2012

Conditions
Obstructive Sleep ApneaCentral Sleep Apnea (Diagnosis)Chronic Opioid Use
Interventions
DEVICE

Adaptive servo-ventilation (ASV)

Adaptive servo-ventilation (ASV) is a form of positive airway pressure (PAP) that is delivered based on the needs of the individual.

DEVICE

Bi-Level PAP

Bi-Level PAP delivers therapy at 2 pressures IPAP and EPAP that are fixed.

Trial Locations (1)

94603

Stanford Center for Human Sleep Research, Redwood City

Sponsors

Lead Sponsor

ResMed
All Listed Sponsors
lead

ResMed

INDUSTRY